Sagimet Biosciences SGMT
NASDAQ SGMT
$10.00 +0.67 (+7.18%)
As of: Sep 30, 2026 · 3:59 PM EDT

Sagimet Biosciences (SGMT) Other financing activities (2022 - 2024)

Updated

Sagimet Biosciences (SGMT) reported Other financing activities of $1.05 million for FY2024, down 70.3% from $3.52 million in FY2023.

Analysis

Sagimet Biosciences (SGMT) Other financing activities (2022 - 2024) Analysis & Trends

  • According to Business Quant data, Other financing activities came in at $3.52 million in FY2023 and $85,000 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Sagimet Biosciences 495.56 Mn 495.56 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 27,000.00
Mar 31, 2024 1.02 Mn
Jun 30, 2023 910,000.00
Mar 31, 2023 136,000.00
Dec 31, 2022 55,000.00
API Access

Sagimet Biosciences Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=SGMT&period=max&api_key=YOUR_API_KEY